Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil in spine surgery
IRCT20190618043934N27Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Dexmedetomidine arm with Remifentanil arm (2 arms). Primary endpoints: Intraoperative blood pressure, Intraoperative heart rate and 1 more. Started Aug 2024; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190618043934N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043934N27.